Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yagmur Akdag. (2023) Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility. Pharmaceutical Development and Technology 28:1, pages 124-137.
Read now
Read now
Ashlee D. Brunaugh, Shivam Sharma & Hugh Smyth. (2021) Inhaled fixed-dose combination powders for the treatment of respiratory infections. Expert Opinion on Drug Delivery 18:8, pages 1101-1115.
Read now
Read now
Douweh Leyla Gbian & Abdelwahab Omri. (2021) Current and novel therapeutic strategies for the management of cystic fibrosis. Expert Opinion on Drug Delivery 18:5, pages 535-552.
Read now
Read now
Jana Kozáková, Ayça Altay, Vladimír Ždímal, Ludmila Mašková, Fabio Sonvico, Eride Quarta, Alessandra Rossi, Francesca Buttini & Gaia Colombo. (2019) Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction. Drug Development and Industrial Pharmacy 45:10, pages 1664-1673.
Read now
Read now
Edit Benke, Árpád Farkas, Imre Balásházy, Piroska Szabó-Révész & Rita Ambrus. (2019) Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and in vitro–in silico lung deposition results. Drug Development and Industrial Pharmacy 45:8, pages 1369-1378.
Read now
Read now
Marek Ochowiak, Magdalena Matuszak & Sylwia Włodarczak. (2017) The analysis of pneumatic atomization of Newtonian and non-Newtonian fluids for different medical nebulizers. Drug Development and Industrial Pharmacy 43:12, pages 1999-2010.
Read now
Read now
Articles from other publishers (19)
Nazareth Eliana Ceschan, Verónica Bucalá & M. Verónica Ramírez-Rigo. (2024) Levofloxacin dry powder inhaler for high dose delivery. Powder Technology 432, pages 119168.
Crossref
Crossref
Hend I. Shahin & Lipika Chablani. (2023) A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications. Journal of Drug Delivery Science and Technology 84, pages 104553.
Crossref
Crossref
Teerapol Srichana, Ekawat Thawithong, Titpawan Nakpheng & Pijush Kumar Paul. (2023) Flow cytometric analysis, confocal laser scanning microscopic, and holotomographic imaging demonstrate potentials of levofloxacin dry powder aerosols for TB treatment. Journal of Drug Delivery Science and Technology 84, pages 104464.
Crossref
Crossref
Aljoscha Gabelmann, Claus-Michael Lehr & Holger Grohganz. (2023) Preparation of Co-Amorphous Levofloxacin Systems for Pulmonary Application. Pharmaceutics 15:6, pages 1574.
Crossref
Crossref
Ardiyah Nurul Fitri Marzaman, Tri Puspita Roska, Sartini Sartini, Rifka Nurul Utami, Sulistiawati Sulistiawati, Cindy Kristina Enggi, Marianti A. Manggau, Latifah Rahman, Venkatram Prasad Shastri & Andi Dian Permana. (2023) Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes. Antibiotics 12:5, pages 822.
Crossref
Crossref
Turki Al Hagbani, Bhavya Vishwa, Amr S. Abu Lila, Hadil Faris Alotaibi, El-Sayed Khafagy, Afrasim Moin & Devegowda V. Gowda. (2022) Pulmonary Targeting of Levofloxacin Using Microsphere-Based Dry Powder Inhalation. Pharmaceuticals 15:5, pages 560.
Crossref
Crossref
Aysu YURDASİPER. (2022) Development of Triamcinolone Acetonide Loaded Poly(lactide-co-glycolic acid) Dry Powder Inhaler Formulations For The Treatment of Asthma. Clinical and Experimental Health Sciences 12:1, pages 249-256.
Crossref
Crossref
Malihe Karimi, Hossein Kamali, Marzieh Mohammadi & Mohsen Tafaghodi. (2022) Evaluation of various techniques for production of inhalable dry powders for pulmonary delivery of peptide and protein. Journal of Drug Delivery Science and Technology 69, pages 103186.
Crossref
Crossref
Nasser Alhajj, Niall J. O'Reilly & Helen Cathcart. (2022) Developing ciprofloxacin dry powder for inhalation: A story of challenges and rational design in the treatment of cystic fibrosis lung infection. International Journal of Pharmaceutics 613, pages 121388.
Crossref
Crossref
Shweta Agarwal, Abhishek Sharma, Chetna Hemrajani & Poonam Negi. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
303
332
.
Aditi Aiyer, Simone K. Visser, Peter Bye, Warwick J. Britton, Gregory S. Whiteley, Trevor Glasbey, Frederik H. Kriel, Jessica Farrell, Theerthankar Das & Jim Manos. (2021) Effect of N-Acetylcysteine in Combination with Antibiotics on the Biofilms of Three Cystic Fibrosis Pathogens of Emerging Importance. Antibiotics 10:10, pages 1176.
Crossref
Crossref
Irene Rossi, Ruggero Bettini & Francesca Buttini. (2021) Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products. Current Pharmaceutical Design 27:12, pages 1436-1452.
Crossref
Crossref
Jorge F. Pontes & Ana Grenha. (2020) Multifunctional Nanocarriers for Lung Drug Delivery. Nanomaterials 10:2, pages 183.
Crossref
Crossref
Aljoscha Koenneke, Marcel Pourasghar & Marc Schneider. 2020. Delivery of Drugs. Delivery of Drugs
119
160
.
Edina Szabó, Balázs Démuth, Dorián László Galata, Panna Vass, Edit Hirsch, István Csontos, György Marosi & Zsombor K. Nagy. (2019) Continuous Formulation Approaches of Amorphous Solid Dispersions: Significance of Powder Flow Properties and Feeding Performance. Pharmaceutics 11:12, pages 654.
Crossref
Crossref
Nashrawan Lababidi, Eric Ofosu Kissi, Walid A.M. Elgaher, Valentin Sigal, Jörg Haupenthal, Bianca C. Schwarz, Anna K.H. Hirsch, Thomas Rades & Marc Schneider. (2019) Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis. Journal of Controlled Release 314, pages 62-71.
Crossref
Crossref
Nagaia Ciacci, Selene Boncompagni, Felice Valzano, Lisa Cariani, Stefano Aliberti, Francesco Blasi, Simona Pollini, Gian Maria Rossolini & Lucia Pallecchi. (2019) In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia. Antibiotics 8:3, pages 101.
Crossref
Crossref
Mariela Razuc, Juliana Piña & María V. Ramírez-Rigo. (2018) Optimization of Ciprofloxacin Hydrochloride Spray-Dried Microparticles for Pulmonary Delivery Using Design of Experiments. AAPS PharmSciTech 19:7, pages 3085-3096.
Crossref
Crossref
Arcadia Woods & Khondaker Miraz Rahman. (2018) Antimicrobial molecules in the lung: formulation challenges and future directions for innovation. Future Medicinal Chemistry 10:5, pages 575-604.
Crossref
Crossref